Page last updated: 2024-11-04

suramin and Coronary Restenosis

suramin has been researched along with Coronary Restenosis in 1 studies

Suramin: A polyanionic compound with an unknown mechanism of action. It is used parenterally in the treatment of African trypanosomiasis and it has been used clinically with diethylcarbamazine to kill the adult Onchocerca. (From AMA Drug Evaluations Annual, 1992, p1643) It has also been shown to have potent antineoplastic properties.
suramin : A member of the class of phenylureas that is urea in which each of the amino groups has been substituted by a 3-({2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl}carbamoyl)phenyl group. An activator of both the rabbit skeletal muscle RyR1 and sheep cardiac RyR2 isoform ryanodine receptor channels, it has been used for the treatment of human African trypanosomiasis for over 100 years.

Coronary Restenosis: Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.

Research Excerpts

ExcerptRelevanceReference
"Suramin is known to inhibit proliferation of various tumor cells."1.31Suramin inhibits proliferation of human arterial smooth muscle cells in vitro: potential drug for prevention of restenosis by local drug delivery. ( Bienert, H; Engisch, R; Günther, RW; Schürmann, K; vom Dahl, J; Vorwerk, D; Voss, M, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Engisch, R1
Schürmann, K1
Bienert, H1
vom Dahl, J1
Voss, M1
Günther, RW1
Vorwerk, D1

Other Studies

1 other study available for suramin and Coronary Restenosis

ArticleYear
Suramin inhibits proliferation of human arterial smooth muscle cells in vitro: potential drug for prevention of restenosis by local drug delivery.
    Journal of vascular and interventional radiology : JVIR, 2000, Volume: 11, Issue:5

    Topics: Arteries; Cell Culture Techniques; Cell Division; Cell Survival; Coronary Restenosis; Drug Delivery

2000